Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Biogen reported $6.28B in Debt for its fiscal quarter ending in March of 2023.

Debt Change
Acorda Therapeutics ACOR:US USD 171.5M 4.46M
Amgen AMGN:US USD 61.6B 22.65B
Bayer BAYN:GR EUR 43.3B 1.65B
Biogen BIIB:US USD 6.28B 1.7M
BioMarin Pharmaceutical BMRN:US USD 1.08B 1.48M
Bristol-Myers Squibb BMY:US USD 37.83B 1.49B
Eli Lilly LLY:US USD 18.88B 2.64B
Esperion Therapeutics ESPR:US USD 260.32M 417K
Incyte Corp INCY:US USD 32.85M 414K
Intercept Pharmaceuticals ICPT:US USD 333.04M 367K
Marinus Pharmaceuticals MRNS:US USD 71.5M 480K
Moderna Inc MRNA:US USD 984M 89M
Neurocrine Biosciences NBIX:US USD 169.5M 100K
Novartis NOVN:VX USD 29.15B 1.24B
PTC Therapeutics PTCT:US USD 1.35B 3.4M
Puma Biotechnology PBYI:US USD 98.62M 316K
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 20.69B 521M
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 417.6M 13.2M